Skip to content

Effect of Evening Primrose Oil on cervical ripening and pregnancy outcomes

The effect of oral Evening Primrose Oil on cervical ripening and pregnancy outcomes in nulliparous women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201507022248N17
Enrollment
80
Registered
2015-08-19
Start date
2015-07-27
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ripening of cervix. Complications of labour and delivery

Interventions

Intervention 1: Oral Evening primrose capsules, from (40 weeks) to ( 40 +6 weeks) , 2 capsules of1000 mg every 12 hours daily for a week ( Manufacturing by Traditional Medicine Research Center Shahed
Treatment - Drugs
Placebo
Oral Evening primrose capsules, from (40 weeks) to ( 40 +6 weeks) , 2 capsules of1000 mg every 12 hours daily for a week ( Manufacturing by Traditional Medicine Research Center Shahed University)
Placebo capsule containing gelatin, 50 mg, 2 capsules every 12 hours daily for a week ( Manufacturing by Traditional Medicine Research Center Shahed University)

Sponsors

Vice Chancellor for research of the international branch of Iran University of Medical science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criterias: cephalic presentation; alive fetus; with gestational age 40 weeks to (40 weeks + 6 days) based on LMP or ultrasound in first trimester; Normal patterns of fetal heart rate; Without uterine contractions; cervical bishop score less than 4 intact membranous; Maternal height more than 150 cm; non-addicted persons; normal adjusted BPP at the time of inclusion;An ultrasound of the placental grading;weight of fetus between 2500-4000 grams based on physical examination or ultrasonography; Low-risk pregnancy ( have no known surgical and internal disease or pregnancy complication such as previa, abruption, preeclampsia , no known fetal problems;Avoiding the enema, Intercourse, laxatives, the use of herbal medicines, chemical or traditional methods for induction of labor; Lack of vaginal examination 24 hours before the begining till end of the study; Exclusion criterias: appears possible side effects of drugs such as headache, nausea, diarrhea and etc, those who consume them is less than two capsule per day, withdrew from the partnership at any stage of the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Ripening Of cervix. Timepoint: During the first week of intervention and labor. Method of measurement: bishop score Table.

Secondary

MeasureTime frame
Duration of first? second and third stages of labor. Timepoint: During the first week of intervention and labor. Method of measurement: chronometer/Examination /check list/observation.;Type of delivery. Timepoint: During the first week of intervention and labor. Method of measurement: End of study/observation.;Infant apgar score. Timepoint: first and fifth minute after delivery. Method of measurement: 7 and more, under 7(According to Apgar table).;Neonatal transport to NICU. Timepoint: During the first 24 hours after childbirth. Method of measurement: check list.;Induction. Timepoint: During the labor. Method of measurement: check list/observation.;The duration of using oxytocin in the active phase. Timepoint: During labor. Method of measurement: chronometer/check list/observation.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmahnaz kalati

The international branch of Iran University of Medical Sciences and Heath

mahnazkalati77@yahoo.com+98 21 8670 2031

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026